In gastrointestinal cancers, lung cancer, glioma, melanoma, prostate cancer, and pancreatic cancer, over-activation of the Kyn pathway, particularly IDO, predicts poor prognosis [18]. The gene discussed is IDO1; the disease is central nervous system cancer.